Trung Ho, MD
Plastic and Reconstructive Surgery · Lufkin, TXNPI 1205151545
Payments from drug & device makers
What this record shows
This record is dominated by education: $645 of the $895 with a category attached, or 72.1%. Pylant Medical accounts for 72.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $697 and has fallen 97.5% since, to $17 in 2023. That places this record below the midpoint for plastic and reconstructive surgery clinicians in TX, where the typical reported total is $2,813.
Across 14 payments — averaging $63.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$645
- Axogen$72
- Integra Lifesciences Corporation$69
- Endo Pharmaceuticals Inc.$57
- TELA Bio, Inc.$18
- AbbVie$17
- plus $17 from 1 others
What the payments were for
- Food & beverage$25028%
- Education$64572%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 1 | $645 |
| Axogen | 2 | $72 |
| Integra Lifesciences Corporation | 3 | $69 |
| Endo Pharmaceuticals Inc. | 4 | $57 |
| TELA Bio, Inc. | 2 | $18 |
| AbbVie | 1 | $17 |
| Smith+Nephew | 1 | $17 |
How this compares
$895 in reported general payments places this provider in the 20th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $455 |
| Minocycline Hcl | 13 | $165 |
| Tramadol Hcl | 65 | $132 |
| Cephalexin | 26 | $108 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Lufkin
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Alina SholarAustin$110K
- Ashley SteinbergBellaire$102K
- Eric MinnsLubbock$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.